Cepheid Recalls One of Its MRSA Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid said after the market closed Thursday that it has initiated a recall of all lots of its Xpert MRSA/SA blood culture product because it produces false-negative MRSA (methicillin-resistant Staphylococcus aureus) results, which could potentially contribute to incorrect treatment of an MRSA infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.